Surrozen, Inc. Profile Avatar - Palmy Investing

Surrozen, Inc.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, includi…

Biotechnology
US, South San Francisco [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of SRZN's Analysis
CIK: 1824893 CUSIP: 86889P109 ISIN: US86889P2083 LEI: - UEI: -
Secondary Listings
SRZN has no secondary listings inside our databases.